Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05590715 · ClinicalTrials.gov registry record

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

A clinical trial of Autism Spectrum Disorder, sponsored by Stalicla.

Recruiting
Registry status
1,500
Enrollment target
20
Study locations

NCT05590715 is a study of Autism Spectrum Disorder that is actively recruiting participants, run by Stalicla. The registered enrollment target is 1,500 participants, above the 129-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (1063% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05590715, a study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Stalicla.

RECRUITING
Registry status
1,500 participants
Enrollment target
20
Study locations

Study Summary

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Conditions Studied

Autism Spectrum Disorder

Study Locations (20)

Other

  • Hospital General Universitario Dr Balmis - Alicante
  • Hospital Clinic of Barcelona - Barcelona
  • Hospital Infantil Universitario Nino Jesus (HIUNJS) - Madrid
  • Hospital universitario Infanta Leonor - Madrid
  • Hospital Universitario Puerta De Hierro Majadahonda - Majadahonda
  • Policlina Gipuzkoa - San Sebastián

Florida

  • BioPhase Research - Miami
  • The Angel Medical Research - Miami Lakes

Queensland

  • Children's Health Queensland Hospital and Health Service - South Brisbane
  • Mater Misericordiae Limited - South Brisbane

Victoria

  • Locuspsych - Melbourne
  • Murdoch Children's Research Institute - Parkville

Arizona

  • SARRC - Phoenix

California

  • California Neuroscience Research - Sherman Oaks

Illinois

  • Rush University Medical Center - Chicago

Missouri

  • University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders - Columbia

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2022-10-13
Est. Completion 2025-12-31

Sponsor

Stalicla

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05590715

The ClinicalTrials.gov registry entry for NCT05590715 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 129-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (1063% higher). The listed sponsor is Stalicla, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT05590715 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Other, Florida, Queensland.

Frequently Asked Questions

What is clinical trial NCT05590715 about?

NCT05590715 is a clinical study titled "International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder". To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

What is the current status of trial NCT05590715?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2022-10-13. Estimated completion is 2025-12-31.

What conditions does trial NCT05590715 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

Who is sponsoring clinical trial NCT05590715?

This trial is sponsored by Stalicla, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05590715 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.